VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $60,445,000 | -23.2% | 338,853 | -4.4% | 6.27% | -16.4% |
| Q2 2015 | $78,708,000 | -2.7% | 354,303 | -13.0% | 7.50% | -5.8% |
| Q1 2015 | $80,859,000 | +21.3% | 407,103 | -12.6% | 7.96% | +9.9% |
| Q4 2014 | $66,675,000 | -14.6% | 465,903 | -21.7% | 7.24% | -20.3% |
| Q3 2014 | $78,091,000 | +3.9% | 595,203 | -0.1% | 9.09% | +7.6% |
| Q2 2014 | $75,155,000 | -7.5% | 595,903 | -3.3% | 8.45% | -11.8% |
| Q1 2014 | $81,208,000 | +5.6% | 616,003 | -5.9% | 9.57% | +0.5% |
| Q4 2013 | $76,886,000 | +0.2% | 654,903 | -10.9% | 9.53% | -7.5% |
| Q3 2013 | $76,725,000 | +12.0% | 735,403 | -7.6% | 10.30% | +0.2% |
| Q2 2013 | $68,498,000 | – | 795,743 | – | 10.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |